UnitedHealth – Capital Expenditure

Quarterly charts & data from official filings

Timeframe

Capital expenditure

Capital expenditureTable view

Earnings release date
Capital expenditure
Earnings release date:16 Jul. 26
Capital expenditure:
799,000,000 $+4.7%
Earnings release date:21 Apr. 26
Capital expenditure:
763,000,000 $-19.5%
Earnings release date:27 Jan. 26
Capital expenditure:
948,000,000 $+6.5%
Earnings release date:28 Oct. 25
Capital expenditure:
890,000,000 $+0.5%
Earnings release date:29 Jul. 25
Capital expenditure:
886,000,000 $-1.3%
Earnings release date:17 Apr. 25
Capital expenditure:
898,000,000 $-1.5%
Earnings release date:16 Jan. 25
Capital expenditure:
912,000,000 $-8.0%
Earnings release date:15 Oct. 24
Capital expenditure:
991,000,000 $+16.2%
Earnings release date:16 Jul. 24
Capital expenditure:
853,000,000 $+14.8%
Earnings release date:16 Apr. 24
Capital expenditure:
743,000,000 $-22.5%
Earnings release date:12 Jan. 24
Capital expenditure:
959,000,000 $+14.4%
Earnings release date:13 Oct. 23
Capital expenditure:
838,000,000 $+1.1%
Earnings release date:14 Jul. 23
Capital expenditure:
829,000,000 $+9.1%
Earnings release date:14 Apr. 23
Capital expenditure:
760,000,000 $-12.2%
Earnings release date:13 Jan. 23
Capital expenditure:
866,000,000 $+19.6%
Earnings release date:14 Oct. 22
Capital expenditure:
724,000,000 $

Revenue by segment

Revenue by segmentTable view

Earnings release date
UnitedHealthcare
Optum Health
Optum Insight
Optum Rx
Eliminations
Total
Earnings release date:16 Jul. 26
UnitedHealthcare:
86,017,000,000 $-0.3%
Optum Health:
23,472,000,000 $-2.6%
Optum Insight:
5,402,000,000 $+5.4%
Optum Rx:
38,292,000,000 $+7.2%
Eliminations:
-41,151,000,000 $-4.1%
Total:
112,032,000,000 $+0.3%
Earnings release date:21 Apr. 26
UnitedHealthcare:
86,265,000,000 $-1.0%
Optum Health:
24,109,000,000 $-5.6%
Optum Insight:
5,125,000,000 $+1.6%
Optum Rx:
35,736,000,000 $-13.8%
Eliminations:
-39,514,000,000 $+14.0%
Total:
111,721,000,000 $-1.3%
Earnings release date:27 Jan. 26
UnitedHealthcare:
87,113,000,000 $+0.0%
Optum Health:
25,543,000,000 $-1.4%
Optum Insight:
5,044,000,000 $+2.6%
Optum Rx:
41,456,000,000 $+4.5%
Eliminations:
-45,941,000,000 $-3.5%
Total:
113,215,000,000 $+0.0%
Earnings release date:28 Oct. 25
UnitedHealthcare:
87,070,000,000 $+1.1%
Optum Health:
25,900,000,000 $+2.8%
Optum Insight:
4,915,000,000 $+1.8%
Optum Rx:
39,679,000,000 $+3.2%
Eliminations:
-44,403,000,000 $-3.3%
Total:
113,161,000,000 $+1.4%
Earnings release date:29 Jul. 25
UnitedHealthcare:
86,103,000,000 $+1.8%
Optum Health:
25,205,000,000 $-0.4%
Optum Insight:
4,828,000,000 $+4.3%
Optum Rx:
38,459,000,000 $+9.5%
Eliminations:
-42,979,000,000 $-7.1%
Total:
111,616,000,000 $+1.9%
Earnings release date:17 Apr. 25
UnitedHealthcare:
84,617,000,000 $+14.1%
Optum Health:
25,309,000,000 $-1.4%
Optum Insight:
4,630,000,000 $-3.2%
Optum Rx:
35,132,000,000 $-1.8%
Eliminations:
-40,113,000,000 $-1.4%
Total:
109,575,000,000 $+8.7%
Earnings release date:16 Jan. 25
UnitedHealthcare:
74,132,000,000 $-1.0%
Optum Health:
25,660,000,000 $-1.0%
Optum Insight:
4,781,000,000 $-3.0%
Optum Rx:
35,774,000,000 $+4.6%
Eliminations:
-39,540,000,000 $-1.2%
Total:
100,807,000,000 $+0.0%
Earnings release date:15 Oct. 24
UnitedHealthcare:
74,853,000,000 $+1.3%
Optum Health:
25,917,000,000 $-4.2%
Optum Insight:
4,931,000,000 $+8.5%
Optum Rx:
34,207,000,000 $+5.5%
Eliminations:
-39,088,000,000 $-0.2%
Total:
100,820,000,000 $+2.0%
Earnings release date:16 Jul. 24
UnitedHealthcare:
73,866,000,000 $-2.0%
Optum Health:
27,050,000,000 $+1.2%
Optum Insight:
4,543,000,000 $+0.9%
Optum Rx:
32,415,000,000 $+5.1%
Eliminations:
-39,019,000,000 $-3.7%
Total:
98,855,000,000 $-0.9%
Earnings release date:16 Apr. 24
UnitedHealthcare:
75,357,000,000 $+6.4%
Optum Health:
26,731,000,000 $+9.0%
Optum Insight:
4,502,000,000 $-5.9%
Optum Rx:
30,835,000,000 $-1.1%
Eliminations:
-37,629,000,000 $-2.1%
Total:
99,796,000,000 $+5.7%
Earnings release date:12 Jan. 24
UnitedHealthcare:
70,808,000,000 $+1.4%
Optum Health:
24,534,000,000 $+2.8%
Optum Insight:
4,785,000,000 $-3.9%
Optum Rx:
31,166,000,000 $+8.0%
Eliminations:
-36,866,000,000 $-4.8%
Total:
94,427,000,000 $+2.2%
Earnings release date:13 Oct. 23
UnitedHealthcare:
69,853,000,000 $-0.5%
Optum Health:
23,864,000,000 $-0.2%
Optum Insight:
4,977,000,000 $+6.5%
Optum Rx:
28,857,000,000 $+0.7%
Eliminations:
-35,190,000,000 $-1.8%
Total:
92,361,000,000 $-0.6%
Earnings release date:14 Jul. 23
UnitedHealthcare:
70,231,000,000 $-0.3%
Optum Health:
23,917,000,000 $+4.0%
Optum Insight:
4,674,000,000 $+4.0%
Optum Rx:
28,646,000,000 $+4.5%
Eliminations:
-34,565,000,000 $-3.3%
Total:
92,903,000,000 $+1.1%
Earnings release date:14 Apr. 23
UnitedHealthcare:
70,468,000,000 $+11.8%
Optum Health:
23,004,000,000 $+24.7%
Optum Insight:
4,496,000,000 $+2.5%
Optum Rx:
27,418,000,000 $+6.0%
Eliminations:
-33,455,000,000 $-15.6%
Total:
91,931,000,000 $+11.0%
Earnings release date:13 Jan. 23
UnitedHealthcare:
63,046,000,000 $+1.7%
Optum Health:
18,446,000,000 $-0.1%
Optum Insight:
4,387,000,000 $+18.8%
Optum Rx:
25,854,000,000 $+2.6%
Eliminations:
-28,946,000,000 $-1.7%
Total:
82,787,000,000 $+2.3%
Earnings release date:14 Oct. 22
UnitedHealthcare:
61,995,000,000 $
Optum Health:
18,463,000,000 $
Optum Insight:
3,693,000,000 $
Optum Rx:
25,203,000,000 $
Eliminations:
-28,460,000,000 $
Total:
80,894,000,000 $

Operating expenses

Operating expensesTable view

Earnings release date
Medical costs
Operating costs
Cost of products sold
Depreciation and amortization
Total
Earnings release date:16 Jul. 26
Medical costs:
75,358,000,000 $+2.5%
Operating costs:
14,268,000,000 $-7.3%
Cost of products sold:
13,375,000,000 $+4.3%
Depreciation and amortization:
1,040,000,000 $+1.1%
Total:
104,041,000,000 $+1.3%
Earnings release date:21 Apr. 26
Medical costs:
73,489,000,000 $-10.4%
Operating costs:
15,390,000,000 $-9.5%
Cost of products sold:
12,823,000,000 $+1.1%
Depreciation and amortization:
1,029,000,000 $-7.9%
Total:
102,731,000,000 $-9.0%
Earnings release date:27 Jan. 26
Medical costs:
82,041,000,000 $+2.6%
Operating costs:
16,997,000,000 $+11.7%
Cost of products sold:
12,680,000,000 $+0.9%
Depreciation and amortization:
1,117,000,000 $+1.6%
Total:
112,835,000,000 $+3.7%
Earnings release date:28 Oct. 25
Medical costs:
79,958,000,000 $+1.7%
Operating costs:
15,223,000,000 $+10.5%
Cost of products sold:
12,566,000,000 $-3.5%
Depreciation and amortization:
1,099,000,000 $+1.4%
Total:
108,846,000,000 $+2.2%
Earnings release date:29 Jul. 25
Medical costs:
78,585,000,000 $+7.0%
Operating costs:
13,778,000,000 $+1.4%
Cost of products sold:
13,019,000,000 $+5.1%
Depreciation and amortization:
1,084,000,000 $+2.2%
Total:
106,466,000,000 $+6.0%
Earnings release date:17 Apr. 25
Medical costs:
73,411,000,000 $+9.5%
Operating costs:
13,594,000,000 $+8.8%
Cost of products sold:
12,390,000,000 $-0.6%
Depreciation and amortization:
1,061,000,000 $+1.9%
Total:
100,456,000,000 $+8.0%
Earnings release date:16 Jan. 25
Medical costs:
67,035,000,000 $+1.6%
Operating costs:
12,494,000,000 $-5.9%
Cost of products sold:
12,464,000,000 $+5.3%
Depreciation and amortization:
1,041,000,000 $+0.0%
Total:
93,034,000,000 $+1.0%
Earnings release date:15 Oct. 24
Medical costs:
65,957,000,000 $+0.8%
Operating costs:
13,280,000,000 $+0.9%
Cost of products sold:
11,834,000,000 $+4.4%
Depreciation and amortization:
1,041,000,000 $+2.1%
Total:
92,112,000,000 $+1.2%
Earnings release date:16 Jul. 24
Medical costs:
65,458,000,000 $-0.4%
Operating costs:
13,162,000,000 $-6.5%
Cost of products sold:
11,340,000,000 $+2.6%
Depreciation and amortization:
1,020,000,000 $+2.3%
Total:
90,980,000,000 $-1.0%
Earnings release date:16 Apr. 24
Medical costs:
65,735,000,000 $+5.6%
Operating costs:
14,077,000,000 $+5.5%
Cost of products sold:
11,056,000,000 $+8.5%
Depreciation and amortization:
997,000,000 $+2.4%
Total:
91,865,000,000 $+5.9%
Earnings release date:12 Jan. 24
Medical costs:
62,231,000,000 $+4.5%
Operating costs:
13,339,000,000 $-3.7%
Cost of products sold:
10,194,000,000 $+8.2%
Depreciation and amortization:
974,000,000 $-3.3%
Total:
86,738,000,000 $+3.5%
Earnings release date:13 Oct. 23
Medical costs:
59,550,000,000 $-1.2%
Operating costs:
13,855,000,000 $+0.3%
Cost of products sold:
9,423,000,000 $-3.3%
Depreciation and amortization:
1,007,000,000 $-1.4%
Total:
83,835,000,000 $-1.2%
Earnings release date:14 Jul. 23
Medical costs:
60,268,000,000 $+0.7%
Operating costs:
13,809,000,000 $+1.4%
Cost of products sold:
9,748,000,000 $+3.6%
Depreciation and amortization:
1,021,000,000 $+5.3%
Total:
84,846,000,000 $+1.2%
Earnings release date:14 Apr. 23
Medical costs:
59,845,000,000 $+11.7%
Operating costs:
13,625,000,000 $+4.7%
Cost of products sold:
9,405,000,000 $+13.1%
Depreciation and amortization:
970,000,000 $-1.2%
Total:
83,845,000,000 $+10.5%
Earnings release date:13 Jan. 23
Medical costs:
53,591,000,000 $+1.8%
Operating costs:
13,009,000,000 $+11.5%
Cost of products sold:
8,314,000,000 $+0.1%
Depreciation and amortization:
982,000,000 $+18.6%
Total:
75,896,000,000 $+3.4%
Earnings release date:14 Oct. 22
Medical costs:
52,635,000,000 $
Operating costs:
11,663,000,000 $
Cost of products sold:
8,306,000,000 $
Depreciation and amortization:
828,000,000 $
Total:
73,432,000,000 $

Profitability

ProfitabilityTable view

Earnings release date
Net income (shareholders)
Free cash flow
Total
Earnings release date:16 Jul. 26
Net income (shareholders):
5,484,000,000 $-12.7%
Free cash flow:
10,253,000,000 $+25.8%
Total:
15,737,000,000 $+9.1%
Earnings release date:21 Apr. 26
Net income (shareholders):
6,280,000,000 $+62700.0%
Free cash flow:
8,149,000,000 $+4993.1%
Total:
14,429,000,000 $+8387.6%
Earnings release date:27 Jan. 26
Net income (shareholders):
10,000,000 $-99.6%
Free cash flow:
160,000,000 $-96.8%
Total:
170,000,000 $-97.7%
Earnings release date:28 Oct. 25
Net income (shareholders):
2,348,000,000 $-31.1%
Free cash flow:
5,055,000,000 $-19.8%
Total:
7,403,000,000 $-23.7%
Earnings release date:29 Jul. 25
Net income (shareholders):
3,406,000,000 $-45.9%
Free cash flow:
6,302,000,000 $+38.3%
Total:
9,708,000,000 $-10.5%
Earnings release date:17 Apr. 25
Net income (shareholders):
6,292,000,000 $+13.5%
Free cash flow:
4,558,000,000 $+212.8%
Total:
10,850,000,000 $+55.0%
Earnings release date:16 Jan. 25
Net income (shareholders):
5,543,000,000 $-8.5%
Free cash flow:
1,457,000,000 $-88.8%
Total:
7,000,000,000 $-63.2%
Earnings release date:15 Oct. 24
Net income (shareholders):
6,055,000,000 $+43.6%
Free cash flow:
12,954,000,000 $+119.8%
Total:
19,009,000,000 $+88.0%
Earnings release date:16 Jul. 24
Net income (shareholders):
4,216,000,000 $+399.2%
Free cash flow:
5,893,000,000 $+1369.6%
Total:
10,109,000,000 $+1102.9%
Earnings release date:16 Apr. 24
Net income (shareholders):
-1,409,000,000 $-125.8%
Free cash flow:
401,000,000 $+106.5%
Total:
-1,008,000,000 $-44.6%
Earnings release date:12 Jan. 24
Net income (shareholders):
5,455,000,000 $-6.6%
Free cash flow:
-6,152,000,000 $-201.5%
Total:
-697,000,000 $-105.9%
Earnings release date:13 Oct. 23
Net income (shareholders):
5,841,000,000 $+6.7%
Free cash flow:
6,064,000,000 $-40.6%
Total:
11,905,000,000 $-24.1%
Earnings release date:14 Jul. 23
Net income (shareholders):
5,474,000,000 $-2.4%
Free cash flow:
10,203,000,000 $-34.5%
Total:
15,677,000,000 $-26.0%
Earnings release date:14 Apr. 23
Net income (shareholders):
5,611,000,000 $+17.9%
Free cash flow:
15,567,000,000 $+388.3%
Total:
21,178,000,000 $+3419.4%
Earnings release date:13 Jan. 23
Net income (shareholders):
4,761,000,000 $-9.5%
Free cash flow:
-5,399,000,000 $-130.3%
Total:
-638,000,000 $-102.8%
Earnings release date:14 Oct. 22
Net income (shareholders):
5,262,000,000 $
Free cash flow:
17,825,000,000 $
Total:
23,087,000,000 $

Profit margin in %

Profit margin in %Table view

Earnings release date
Profit margin (shareholders)
Profit margin (free cash flow)
Earnings release date:16 Jul. 26
Profit margin (shareholders):
4.9 %-0.7 pp
Profit margin (free cash flow):
9.15 %+1.9 pp
Earnings release date:21 Apr. 26
Profit margin (shareholders):
5.62 %+5.6 pp
Profit margin (free cash flow):
7.29 %+7.2 pp
Earnings release date:27 Jan. 26
Profit margin (shareholders):
0.01 %-2.1 pp
Profit margin (free cash flow):
0.14 %-4.3 pp
Earnings release date:28 Oct. 25
Profit margin (shareholders):
2.07 %-1.0 pp
Profit margin (free cash flow):
4.47 %-1.2 pp
Earnings release date:29 Jul. 25
Profit margin (shareholders):
3.05 %-2.7 pp
Profit margin (free cash flow):
5.65 %+1.5 pp
Earnings release date:17 Apr. 25
Profit margin (shareholders):
5.74 %+0.2 pp
Profit margin (free cash flow):
4.16 %+2.7 pp
Earnings release date:16 Jan. 25
Profit margin (shareholders):
5.5 %-0.5 pp
Profit margin (free cash flow):
1.45 %-11.4 pp
Earnings release date:15 Oct. 24
Profit margin (shareholders):
6.01 %+1.7 pp
Profit margin (free cash flow):
12.85 %+6.9 pp
Earnings release date:16 Jul. 24
Profit margin (shareholders):
4.26 %+5.7 pp
Profit margin (free cash flow):
5.96 %+5.6 pp
Earnings release date:16 Apr. 24
Profit margin (shareholders):
-1.41 %-7.2 pp
Profit margin (free cash flow):
0.4 %+6.9 pp
Earnings release date:12 Jan. 24
Profit margin (shareholders):
5.78 %-0.5 pp
Profit margin (free cash flow):
-6.52 %-13.1 pp
Earnings release date:13 Oct. 23
Profit margin (shareholders):
6.32 %+0.4 pp
Profit margin (free cash flow):
6.57 %-4.4 pp
Earnings release date:14 Jul. 23
Profit margin (shareholders):
5.89 %-0.2 pp
Profit margin (free cash flow):
10.98 %-6.0 pp
Earnings release date:14 Apr. 23
Profit margin (shareholders):
6.1 %+0.4 pp
Profit margin (free cash flow):
16.93 %+23.5 pp
Earnings release date:13 Jan. 23
Profit margin (shareholders):
5.75 %-0.8 pp
Profit margin (free cash flow):
-6.52 %-28.6 pp
Earnings release date:14 Oct. 22
Profit margin (shareholders):
6.5 %
Profit margin (free cash flow):
22.04 %